Mark Newman, Author at Endocrine News

Society News

Care Package: Christine M. Burt Solorzano, MD, Discusses the Endocrine Society’s Newly Expanded Patient Engagement

Endocrine News talks with Christine M. Burt Solorzano, MD, chair of the committee that helped launch the Endocrine Society’s reinvigorated patient outreach program, EndoCares. With an in-person event taking place in Atlanta during ENDO 2022, EndoCares is set to become an important bridge between the Endocrine Society’s members and the patients they treat. The...

Inaugural Transatlantic Award Recipient Shlomo Melmed to Be Featured at ENDO 2022

Shlomo Melmed, MB, ChB, the first recipient of the Transatlantic Alliance Award from the Endocrine Society and the European Society of Endocrinology (ESE) will be a featured speaker at ENDO 2022. Melmed’s talk, “Growth Hormone: An Adult Endocrine Misnomer,” will be featured in the Presidential Plenary, “Health Equity in Endocrinology” beginning at 2 p.m. on...

Clinical Pearls: Q&A with William F. Young, Jr., MD, Editor-in-Chief of JCEM Case Reports

In anticipation of the Endocrine Society’s new open access journal, JCEM Case Reports, its editor-in-chief, William F. Young, Jr., MD, talks to Endocrine News about how this new journal will have a place for both master clinicians and early-career physicians to present their cases, why it’s important to hear the patient’s perspective, as well as...

Lab Notes
- Q&A

Brainstorming: Q&A with Michael W. Schwartz, MD

Endocrine News talks to Michael W. Schwartz, MD, the 2022 Laureate recipient of the Roy O. Greep Award for Outstanding Research about his life and career in academic research that all started with a fascination with how the brain controls behavior. With his significant contributions in uncovering how our brain regulates energy balance and glucose...

Endocrine Disruptors

Endocrine-Disrupting Chemicals May Impair Bone Health in Teen Boys

Per- and polyfluoroalkyl substances (PFAS) and phthalates (two types of endocrine-disrupting chemicals) may be associated with lower bone mineral density in male teens, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. Endocrine-disrupting chemicals are chemicals or mixtures of chemicals that interfere with the way the body’s hormones work. Per- and...

President's Viewpoint

Ready to Reconnect: ENDO 2022 Offers New Opportunities to Interact with Endocrine Community

After three years, we are finally on the verge of reuniting face-to-face as a community. I cannot wait to see many of you in Atlanta next month for ENDO 2022. While I am excited to catch up in person with those who travel to Atlanta June 11-14, we are committed to learning from and improving...

Research

Advocacy Season for NIH Funding Officially Begins

While 2022 is only a few months old, on Capitol Hill the appropriations cycle for fiscal year (FY) 2023 is well and truly underway and the Endocrine Society has quickly shifted gears and developed our 2023 funding requests for the NIH and other critical public health agencies. In March, the Biden Administration kicked off the...

Endocrine Society Members Advocate for Insulin Affordability, Diabetes Prevention, Diabetes Research

The Endocrine Society conducted a Hill Day over April 26, 27, and 28, where we brought together nearly 55 member clinicians, clinical researchers, and basic scientists from 25 states to meet with their Congressional representatives and discuss issues related to diabetes treatment, prevention, and research. Continuing security restrictions on Capitol Hill required that our meetings...